Manja Meggendorfer

9.5k citations

200 papers · 2.4k indexed · h-index 27

Hematology top 0.5%
Genetics top 1%
Molecular Biology top 10%
Immunology top 10%
Cancer Research top 5%

Co-authors: Torsten Haferlach Claudia Haferlach Wolfgang Kern Susanne Schnittger Anna Stengel Niroshan Nadarajah Wencke Walter Tamara Alpermann
Topics: Acute Myeloid Leukemia Research (129 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (65 papers)Chronic Myeloid Leukemia Treatments (40 papers)
Cited by: Hematology Genetics Cancer Research
Journals: Nature Communications Blood Cancer Research
Partner nations: Germany United States Italy

In The Last Decade

Manja Meggendorfer

168 papers receiving 2.3k citations

Peers

Countries citing papers authored by Manja Meggendorfer

Since Specialization

Citations

This map shows the geographic impact of Manja Meggendorfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manja Meggendorfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manja Meggendorfer more than expected).

Fields of papers citing papers by Manja Meggendorfer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manja Meggendorfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manja Meggendorfer. The network helps show where Manja Meggendorfer may publish in the future.

Co-authorship network of co-authors of Manja Meggendorfer

This figure shows the co-authorship network connecting the top 25 collaborators of Manja Meggendorfer. A scholar is included among the top collaborators of Manja Meggendorfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manja Meggendorfer. Manja Meggendorfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations 2025 ·Leukemia ·Maki Sakuma,(unknown),(unknown),(unknown),Manja Meggendorfer,Wolfgang Kern,Claudia Haferlach,Torsten Haferlach,David B. Beck,Wencke Walter	0
2	Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis 2025 ·Annals of Hematology ·(unknown),Jenny Rinke,Andrew J. Walter,(unknown),Manja Meggendorfer,Constance Baer,Andreas Hochhaus,Thomas Ernst	0
3	Unraveling the germline inheritance of the <i>JAK2</i>F556V gene mutation in familial thrombocythemia: a comprehensive analysis of 11 family members and potential implications for surveillance 2024 ·Haematologica ·Manja Meggendorfer,(unknown),Maria K. Beykirch,Petro E. Petrides	1
4	Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS 2023 ·Blood Advances ·Anna Stengel,Torsten Haferlach,Constance Baer,Stephan Hütter,Manja Meggendorfer,Wolfgang Kern,Claudia Haferlach	16
5	Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets 2023 ·Leukemia ·Minako Mori,Yasuo Kubota,Arda Durmaz,Carmelo Gurnari,Charnise Goodings,Vera Ademà,Ben Ponvilawan,Waled Bahaj,Tariq Kewan,Thomas LaFramboise,Manja Meggendorfer,Claudia Haferlach,John Barnard,Marcin W. Włodarski,Valeria Visconte,Torsten Haferlach,Jaroslaw P. Maciejewski	10
6	Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022 2023 ·Blood ·Francis Baumgartner,Constance Baer,Stefanos A. Bamopoulos,Edward Ayoub,Marietta Truger,Manja Meggendorfer,Miriam Lenk,Gregor Hoermann,Stephan Hütter,Heiko Müller,Wencke Walter,(unknown),Niroshan Nadarajah,Piers Blombery,Ulrich Keller,Wolfgang Kern,Claudia Haferlach,Torsten Haferlach	10
7	Whole Genome Sequencing Identifies Non-KIT Mutations and Cytogenetic Aberrations in Systemic Mastocytosis but Has Limited Sensitivity for Detection of KIT D816V 2021 ·Blood ·Gregor Hoermann,Manja Meggendorfer,Constance Baer,Heiko Müller,Wencke Walter,Stephan Hütter,Christian Pohlkamp,Niroshan Nadarajah,Wolfgang Kern,Torsten Haferlach,Claudia Haferlach	0
8	Benchmarking of Whole Genome Sequencing (WGS) and Whole Transcriptome Sequencing (WTS) As Diagnostic Tools for the Genetic Characterization of Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) in Adults 2021 ·Blood ·Claudia Haferlach,Wencke Walter,Manja Meggendorfer,Anna Stengel,Constance Baer,Stephan Hütter,Niroshan Nadarajah,Heiko Müller,Wolfgang Kern,Torsten Haferlach	2
9	Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia 2021 ·Leukemia ·Sunisa Kongkiatkamon,Simona Pagliuca,Vera Ademà,Yasunobu Nagata,Cassandra M Kerr,Wencke Walter,Hassan Awada,Stephan Hütter,Carmelo Gurnari,Heesun J. Rogers,Manja Meggendorfer,Yogen Saunthararajah,Torsten Haferlach,Valeria Visconte,Jaroslaw P. Maciejewski	3
10	SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia 2021 ·Leukemia ·Inge van der Werf,Anna Wojtuszkiewicz,Huilan Yao,Rocco Sciarrillo,Manja Meggendorfer,Stephan Hütter,Wencke Walter,Jeroen J. W. M. Janssen,Wolfgang Kern,Claudia Haferlach,Torsten Haferlach,Gerrit Jansen,Gertjan J.L. Kaspers,Richard W.J. Groen,Gert J. Ossenkoppele,Jacqueline Cloos	8
11	Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification 2021 ·Blood Advances ·Inge van der Werf,Anna Wojtuszkiewicz,Manja Meggendorfer,Stephan Hütter,Constance Baer,Martijn W. Heymans,Peter J.M. Valk,Wolfgang Kern,Claudia Haferlach,Jeroen J. W. M. Janssen,Gert J. Ossenkoppele,Jacqueline Cloos,Torsten Haferlach	23
12	Complex landscape of alternative splicing in myeloid neoplasms 2020 ·Leukemia ·Courtney E. Hershberger,(unknown),Vera Ademà,Cassandra M Kerr,Wencke Walter,Stephan Hütter,Manja Meggendorfer,Constance Baer,Wolfgang Kern,Niroshan Nadarajah,Sven Twardziok,Mikkael A. Sekeres,Claudia Haferlach,Torsten Haferlach,Jaroslaw P. Maciejewski,Richard A. Padgett	37
13	Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes 2019 ·American Journal of Hematology ·Vikas Madan,Jia Li,Siqin Zhou,(unknown),Lin Han,Manja Meggendorfer,Luca Malcovati,Mario Cazzola,Seishi Ogawa,Torsten Haferlach,Henry Yang,H. Phillip Koeffler	13
14	A Personalized Prediction Model to Risk Stratify Patients with Acute Myeloid Leukemia (AML) Using Artificial Intelligence 2019 ·Blood ·Jacob Shreve,Manja Meggendorfer,Hassan Awada,Sudipto Mukherjee,Wencke Walter,Stephan Hütter,(unknown),(unknown),Nathan Radakovich,Yasunobu Nagata,(unknown),Vera Ademà,Cassandra M Kerr,Bhumika J. Patel,Teodora Kuzmanovic,Jaroslaw P. Maciejewski,Claudia Haferlach,Mikkael A. Sekeres,Torsten Haferlach,Aziz Nazha	15
15	Deletion 7q Is Associated with KLF2 and NOTCH2 Mutations and Is Strongly Correlated with Splenic Marginal Zone Lymphoma but Also Found in Lymphoplasmacytic Lymphoma and Hairy Cell Leukemia Variant 2017 ·Blood ·Alexander Höllein,Anna Stengel,Manja Meggendorfer,Annette Fasan,Wolfgang Kern,Torsten Haferlach,Claudia Haferlach	3
16	Impact of 9q Deletions on the Classification in AML 2017 ·Blood ·(unknown),Anna Stengel,Manja Meggendorfer,Annette Fasan,Wolfgang Kern,Torsten Haferlach,Claudia Haferlach	2
17	Deep Learning Algorithms Support Distinction of PV, PMF, and ET Based on Clinical and Genetic Markers 2017 ·Blood ·Manja Meggendorfer,Wencke Walter,Claudia Haferlach,Wolfgang Kern,Torsten Haferlach	3
18	High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Depict a High Complexity on the Cytogenetic, but Not on the Molecular Genetic Level and Show MYC Mutations As Prognostic Marker 2017 ·Blood ·Anna Stengel,Wolfgang Kern,Manja Meggendorfer,Torsten Haferlach,Claudia Haferlach	1
19	Whole Genome Sequencing in Hairy Cell Leukemia-Variant (HCL-v) and Splenic Marginal Zone Lymphoma (SMZL) 2017 ·Blood ·Torsten Haferlach,Niroshan Nadarajah,Manja Meggendorfer,Claudia Haferlach,Wolfgang Kern	1
20	SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML) 2012 ·Blood ·Manja Meggendorfer,Andreas Roller,Torsten Haferlach,Christiane Eder,Frank Dicker,Vera Grossmann,Alexander Kohlmann,Tamara Alpermann,Kenichi Yoshida,Seishi Ogawa,H. Phillip Koeffler,Wolfgang Kern,Claudia Haferlach,Susanne Schnittger	219

About Manja Meggendorfer

Manja Meggendorfer is a scholar working on Hematology, Genetics and Cancer Research, having authored 200 papers that have together received 2.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (129 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (65 papers) and Chronic Myeloid Leukemia Treatments (40 papers). The work is most often cited by research in Hematology (1.5k citations), Genetics (949 citations) and Cancer Research (355 citations). Manja Meggendorfer has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Torsten Haferlach, Claudia Haferlach, Wolfgang Kern, Susanne Schnittger, Anna Stengel, Niroshan Nadarajah, Wencke Walter, Tamara Alpermann, Stephan Hütter and Constance Baer. Their work appears in journals such as Nature Communications, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact